Skip to search formSkip to main contentSkip to account menu

Amyloid Beta 1-40 Measurement

Known as: Amyloid Beta 40, Amyloid Beta 40 Protein, Amyloid Beta 1-40 
The determination of the amount of amyloid beta protein which is composed of peptides 1 to 40 in a sample.
National Institutes of Health

Related topics

Related topics

3 relations
CDISC SDTM Laboratory Test Terminology by CodeCDISC SDTM Laboratory Test Terminology by NameClinical Data Interchange Standards Consortium Terminology

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2018
Review
2018
Vascular ageing: Underlying mechanisms and clinical implications
2014
2014
Engineering Neprilysin Activity and Specificity to Create a Novel Therapeutic for Alzheimer’s Disease
Neprilysin is a transmembrane zinc metallopeptidase that degrades a wide range of peptide substrates. It has received attention… 
Highly Cited
2012
Highly Cited
2012
Graphene oxide as a quencher for fluorescent assay of amino acids, peptides, and proteins.
Understanding the interaction between graphene oxide (GO) and the biomolecules is fundamentally essential, especially for disease… 
Highly Cited
2012
Highly Cited
2012
Lower CSF amyloid beta peptides and higher F2-isoprostanes in cognitively intact elderly individuals with major depressive disorder.
OBJECTIVE Major depressive disorder is common in the elderly, and symptoms are often not responsive to conventional… 
Highly Cited
2009
Highly Cited
2009
Centella asiatica extract selectively decreases amyloid β levels in hippocampus of Alzheimer's disease animal model
PSAPP mice expressing the ‘Swedish’ amyloid precursor protein and the M146L presenilin 1 mutations are a well‐characterized model… 
Highly Cited
2009
Highly Cited
2009
Abeta42-Induced Neurodegeneration via an Age-Dependent Autophagic-Lysosomal Injury in Drosophila
The mechanism of widespread neuronal death occurring in Alzheimer's disease (AD) remains enigmatic even after extensive… 
Highly Cited
2007
Highly Cited
2007
Sustained hippocampal IL-1 beta overexpression mediates chronic neuroinflammation and ameliorates Alzheimer plaque pathology.
Neuroinflammation is a conspicuous feature of Alzheimer disease (AD) pathology and is thought to contribute to the ultimate… 
Highly Cited
2006
Highly Cited
2006
Diagnostic and Therapeutic Potential of Amyloid-Reactive IgG Antibodies Contained in Human Sera1
Passive immunotherapy using fibril-reactive mAbs has been shown experimentally to reduce amyloid formation and also accelerate… 
Highly Cited
2005
Highly Cited
2005
A ketogenic diet reduces amyloid beta 40 and 42 in a mouse model of Alzheimer's disease
BackgroundAlzheimer's disease (AD) is a progressive neurodegenerative disorder that primarily strikes the elderly. Studies in… 
Review
1995
Review
1995
Amyloid beta amyloidosis in Alzheimer's disease.
The presence of amyloid deposits in the parenchyma of the amygdala, hippocampus, and neocortex is a major histopathological… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)